NCT06505694

Brief Summary

This is a virtual randomized placebo-controlled double-blind trial lasting eight weeks. The trial will assess the effects of a test product on improving sleep quality, promoting a sense of calm, and reducing feelings of stress and anxiety, using a sleep tracker and subject-specific questionnaires. The study involves 80 participants who experience sleep issues and feelings associated with stress and anxiety.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 9, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 17, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2024

Completed
Last Updated

April 24, 2025

Status Verified

April 1, 2025

Enrollment Period

3 months

First QC Date

July 11, 2024

Last Update Submit

April 22, 2025

Conditions

Keywords

Sleep QualitySleep TrackerRelaxationHerbal Tincture

Outcome Measures

Primary Outcomes (1)

  • Improvements in Sleep Quality and Mental Well-Being

    Changes in sleep quality, mental well-being, stress, and feelings of anxiety will be assessed using self-assessment questionnaires. Participants will complete these questionnaires at specified intervals throughout the study to evaluate the effectiveness of the herbal tincture compared to the placebo.

    Baseline, Week 2, Week 4, Week 6, and Week 8

Secondary Outcomes (1)

  • Changes in Sleep Length and Quality

    Baseline, Week 4, and Week 8

Study Arms (2)

Test Product Arm

EXPERIMENTAL

Participants in this arm will receive the test product, which is an alcohol alternative herbal tincture. The intervention includes taking 2 ml of the test product directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks.

Dietary Supplement: Alcohol Alternative Herbal Tincture (Test Product)

Placebo Arm

PLACEBO COMPARATOR

Participants in this arm will receive a placebo. The intervention includes taking 2 ml of the placebo directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks.

Dietary Supplement: Placebo

Interventions

The test product contains organic vegetable glycerin, distilled water, organic elderberries, organic bilberries, organic beetroot juice powder, organic California poppy (whole plant), organic tart cherry, organic hawthorn berries, organic blue vervain (aerial parts), organic ceylon cinnamon bark, organic black pepper fruit, and L-theanine.

Test Product Arm
PlaceboDIETARY_SUPPLEMENT

The placebo is designed to match the test product in appearance and taste but does not contain the active herbal ingredients. Participants will take 2 ml of the placebo directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks. The placebo contains organic vegetable glycerin, distilled water, organic beet juice powder, organic tart cherries, organic ceylon cinnamon chips, and natural green food coloring (derived from spirulina and turmeric).

Placebo Arm

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 21-65 years
  • Male or female
  • Good general health
  • Experience daily feelings of stress and anxiety within the past two weeks
  • Experience daily problems with sleeping, reduced energy levels, and fatigue over the past two weeks
  • Have used alcohol products to help relax or sleep within the past two weeks
  • Experience tension in the body within the past two weeks
  • Experience problems with relaxing in the evening within the past two weeks
  • Willing to abstain from alcohol for the duration of the study
  • Willing to maintain stable use of other herbal supplements, over-the-counter medications, or prescriptions during the study

You may not qualify if:

  • Chronic health conditions, including oncological and psychiatric disorders
  • Taking SSRIs, sedative, or blood pressure-lowering medications
  • Pregnant, breastfeeding, or planning to conceive within the next three months
  • Currently enrolled or planning to enroll in another research trial over the next eight weeks
  • History of substance abuse
  • Known serious allergic reactions requiring an Epi-Pen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

MeSH Terms

Conditions

Anxiety DisordersSleep Initiation and Maintenance Disorders

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Mental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double-blind (Participant, Investigator)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 17, 2024

Study Start

May 9, 2024

Primary Completion

August 20, 2024

Study Completion

August 20, 2024

Last Updated

April 24, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations